Torrentino-Madamet Marylin, Fall Bécaye, Benoit Nicolas, Camara Cheikhou, Amalvict Rémy, Fall Mansour, Dionne Pierre, Ba Fall Kadidiatou, Nakoulima Aminata, Diatta Bakary, Diemé Yaya, Ménard Didier, Wade Boubacar, Pradines Bruno
Aix Marseille Université, Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes, UM 63, CNRS 7278, IRD 198, Inserm 1095, Marseille, France.
Malar J. 2014 Dec 4;13:472. doi: 10.1186/1475-2875-13-472.
The emergence of Plasmodium falciparum resistance to artemisinin and its derivatives, manifested as delayed parasite clearance following the treatment, has developed in Southeast Asia. The spread of resistance to artemisinin from Asia to Africa may be catastrophic for malaria control and elimination worldwide. Recently, mutations in the propeller domain of the Kelch 13 (k13) gene (PF3D71343700) were associated with in vitro resistance to artemisinin and with delayed clearance after artemisinin treatment in southern Asia. The aim of the study was to characterize the genetic variability of k13 and to evaluate the molecular resistance to artemisinin for the first time in Senegal.
Plasmodium falciparum isolates were collected from 138 malaria patients in Dakar and its districts during the rainy season of October 2012 to January 2013 at the Hôpital Principal de Dakar. The k13 gene was amplified using nested PCR and sequenced.
A very limited variability within the k13 gene in Senegalese P. falciparum isolates was identified. No polymorphism was detected in the six k13-propeller blades. Only two mutations, T149S (6.3%) and K189T (42.2%), and one (N) or two (NN) asparagine insertion at the codon 142 (4.7 and 6.3%, respectively) were detected in the Plasmodium/Apicomplexa-specific domain. None of the polymorphisms associated with artemisinin resistance in Southeast Asia was detected in the 138 P. falciparum from Dakar.
The present data do not suggest widespread artemisinin resistance in Dakar in 2012-2013. Notably, the C580Y, R539T or Y493H substitutions that were associated with in vitro resistance or delayed parasite clearance in Southeast Asia were not observed in Dakar, nor were any of the polymorphisms observed in parasites from Southeast Asia, nor the M476I mutation that was selected in vitro with artemisinin pressure in a African parasite line.
恶性疟原虫对青蒿素及其衍生物产生耐药性,表现为治疗后寄生虫清除延迟,这一情况已在东南亚出现。青蒿素耐药性从亚洲传播至非洲可能会给全球疟疾防控和消除工作带来灾难性后果。最近,凯尔奇13(k13)基因(PF3D71343700)螺旋桨结构域的突变与南亚体外青蒿素耐药性以及青蒿素治疗后寄生虫清除延迟有关。本研究的目的是首次在塞内加尔对k13的遗传变异性进行表征,并评估对青蒿素的分子耐药性。
2012年10月至2013年1月雨季期间,在达喀尔主要医院从达喀尔及其周边地区的138名疟疾患者中收集恶性疟原虫分离株。使用巢式PCR扩增k13基因并进行测序。
在塞内加尔恶性疟原虫分离株中,k13基因内的变异性非常有限。在六个k13螺旋桨叶片中未检测到多态性。在疟原虫/顶复门特异性结构域中仅检测到两个突变,即T149S(6.3%)和K189T(42.2%),以及密码子142处的一个(N)或两个(NN)天冬酰胺插入(分别为4.7%和6.3%)。在来自达喀尔的138株恶性疟原虫中未检测到与东南亚青蒿素耐药性相关的任何多态性。
目前的数据并不表明2012 - 2013年达喀尔存在广泛的青蒿素耐药性。值得注意的是,在达喀尔未观察到与东南亚体外耐药性或寄生虫清除延迟相关的C580Y、R539T或Y493H替代,也未观察到在东南亚寄生虫中出现的任何多态性,以及在非洲寄生虫株中经青蒿素压力体外选择出的M476I突变。